Literature DB >> 731264

Regional cerebral blood flow in parkinsonism. Measurement before and after levodopa.

E Melamed, S Lavy, G Cooper, S Bentin.   

Abstract

Data from recent studies in experimental animals suggest that central dopaminergic mechanisms may be involved in regulation of the regional cerebral blood flow (rCBF) in the mammalian brain. In order to evaluate possible effects of dopaminergic stimulation on human cerebral circulation, rCBF was measured by the 133Xenon inhalation technique in 26 patients with Parkinson's disease before and after the chronic oral administration of levodopa combined with a peripheral Dopa-decarboxylase inhibitor. Treatment with levodopa did not induce significant alterations in the mean brain, mean hemispheric or regional flow values in these patients. These findings suggest that the dopaminergic system does not play an important role in modulation of the rCBF in man.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 731264     DOI: 10.1016/0022-510x(78)90144-2

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

1.  Regional cerebral blood flow in patients with Parkinson's disease under chronic levodopa therapy: measurements during "on" and "off" response fluctuations.

Authors:  E Melamed; M Globus; B Mildworf
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-11       Impact factor: 10.154

2.  SPECT neuroimaging and neuropsychological functions in different stages of Parkinson's disease.

Authors:  Anna Paschali; Lambros Messinis; Odysseas Kargiotis; Velissarios Lakiotis; Zinovia Kefalopoulou; Costantinos Constantoyannis; Panagiotis Papathanasopoulos; Pavlos Vassilakos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-02-10       Impact factor: 9.236

3.  Technetium-99m hexamethylpropylene amine oxime single photon emission tomography of the brain in early Parkinson's disease: correlation with dementia and lateralization.

Authors:  S J Wang; R S Liu; H C Liu; K N Lin; D E Shan; K K Liao; J L Fuh; L S Lee
Journal:  Eur J Nucl Med       Date:  1993-04

4.  Long term treatment and disease severity change brain responses to levodopa in Parkinson's disease.

Authors:  T Hershey; K J Black; J L Carl; L McGee-Minnich; A Z Snyder; J S Perlmutter
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

5.  Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease.

Authors:  D Rougemont; J C Baron; P Collard; P Bustany; D Comar; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-08       Impact factor: 10.154

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.